Epidemiological Study on Mental Health of Migrant Population in the Retention Center of Geispolsheim.

Epidemiological Study on Mental Health of Migrant Population in the Retention Center of Geispolsheim

In 2019, the lack of studies about mental health of the detained population at retention centers in France is pointed out by the report of Controller-General for Places of Deprivation of Liberty. The aim of this study is to contribute to this relatively untouched field by describing which psychiatric pathologies are encountered in this population who went through migration and retention. Having a clearer picture of the situation can help to provide a more adapted psychiatric care in retention centers.

The results are expected to show a higher rate of psychiatric disease than in the general population including addiction to substance, anxiety disorder and post-traumatic stress disorder (PTSD).

Study Overview

• Status: Unknown
• Conditions: Mental Health of Migrant Population
• Intervention / Treatment: Behavioral: Retention center Geispolsheim population

• Study Type: Observational
• Enrollment (Anticipated): 30

Contacts and Locations

Study Locations

• France
  • Strasbourg, France, 67091
    • Les Hôpitaux Universitaires de Strasbourg

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Male

• Sampling Method: Non-Probability Sample

Study Population

The migrant population in the retention center of Geispolsheim is male migrants residing in France without authorization. Their retention is decided by the prefecture of Bas-Rhin and Haut-Rhin. The retention happens after custody or at the end of a term of imprisonment.

Description

Inclusion Criteria:

• Any male person in the first week of detention at CRA Geispolsheim who gave their non-opposition to participation in the study.
• Information and consent protocol signed

Exclusion Criteria:

• Refuse to participate to the study

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Mini International Neuropsychiatric Interview validated and translated in the language used by the interviewed person.	The interview is led by the investigator in the presence of a translator if necessary.	1 hour

Collaborators and Investigators

• Sponsor: University Hospital, Strasbourg, France

Study record dates

Study Major Dates

• Study Start (Anticipated): May 1, 2020
• Primary Completion (Anticipated): May 1, 2020
• Study Completion (Anticipated): May 1, 2021

Study Registration Dates

• First Submitted: March 30, 2020
• First Submitted That Met QC Criteria: March 30, 2020
• First Posted (Actual): April 1, 2020

Study Record Updates

• Last Update Posted (Actual): April 1, 2020
• Last Update Submitted That Met QC Criteria: March 30, 2020
• Last Verified: March 1, 2020

More Information

Terms related to this study

• Keywords: Mental health; Psychiatric diseases; Migration; Retention center
• Other Study ID Numbers: 7657

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No